American Journal on Addictions

Article	Citations
Issue Information	57
AAAP's Annual Meeting and Scientific Symposium	25
Stand against stigma	24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	21
Self assessment ad (002)	21
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	19
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	19
Issue Information	18
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	17
2024 Annual Meeting Posters	17
Call for Special Issue 2024	17
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	16
AAAP Stimulant Use Disorder PIP	14
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	13
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	13
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	12
AAAP's Self‐Assessment Examination 2020	12
Gender differences in circumstances associated with cannabis use	12
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	12
AAAP Annual meeting ad	10
Issue Information	10
Emotional regulation in Gaming Disorder: A systematic review	9
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults	9
Become a member of AAAP!	9
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China	9

Tobacco use and impulsivity in people with mental illness: A systematic review	9
Narcotics Anonymous members in recovery from methamphetamine use disorder	9
Call for Special Issue Papers 2025	8
Call for Review Papers 2024	8
Correlates of optimism among patients in substance use disorder inpatient treatment	8
AM Registration Flyer	8
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	7
Call for Review Papers 2024	7
Call for Special Issue Papers 2024	7
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	6
Preconference On‐Demand availability	6
Issue Information ‐ Editorial Board	6
Issue Information ‐ ToC	6
	6
Call for review papers 2021	6
Issue Information ‐ Editorial Board	6
Call for review papers 2022	6
Call for Special Issue 2021	6
Issue Information	5
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	5
AAAP Call for Abstracts	5
Stand Against Stigma	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
AAAP AATT Preconference	5
AJA Annual Meeting 2023	5
Extended‐release buprenorphine in pregnancy	5
Issue Information ‐ ToC	5
2023 Advanced Addiction Psychopharmacology Course	5
AAAP 31st Annual Meeting 2020 ‐ Program Guide	5
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	5
AAAP Podcast EP	5
AAAP annual meeting and pre‐conference courses	5
Issue Information ‐ Editorial Board	5
AAAP's Performance in practice activities	5
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	4
Sleep disturbance in clients attending a specialist addiction clinic	4
Registration open – AAAP annual meeting and pre‐conference courses	4
Addiction specialists' attitudes toward psychedelics: A National Survey	4
Health care service utilization and drug overdose death: A national nested case–control registry study	4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
Personality predicting relapse: A facet analysis of the NEO PI‐R	4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
Call for special issue 2023	4
AAAP Membership benefits	3
AJA AM save the date 2023	3
2023 Addictions and Their Treatment Course	3
Call for Symposium Abstracts	3
AAAP PIPS	3
	3

Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
	3
Opioid Response Network	3
Call for Special Issue 2023	3
2021 AJA Reviewer List	3
Issue Information ‐ Editorial Board	3
Mini‐Symposia I	3
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	3
Cannabis Use Disorders Performance in Practice	3
Stand Against Stigma	3
AJA AM Save the Date 2023	3
	3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	2
Save the Date ‐ Annual Meeting 2025	2
Become an AAAP Member	2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts	2
Call for Review Papers 2023	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
AAAP on‐demand educational activities	2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	2
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	2
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	2
Issue Information ‐ Editorial Board	2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
Trends in substance use disorder diagnoses among Veterans, 2009–2019	2
Psychotherapy Webinar Series AJA	2
Medical Update	2
AAAP 2024 Self‐Assessment Exam Now Available	2
2025 Call for Symposium Abstracts	2
Concurrent Paper Sessions	2
Medication Management for Stimulant Use Disorder Webinar	2
Paper sessions	2
Gambling, tobacco use, and health among individuals in substance use disorder treatment	2
Call for special issue 2023	1
Opioid use disorder in the active service: Implications for intervention	1
Call for special issue 2023	1
AJA Annual Meeting 2024	1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
2024 Annual Meeting Posters	1
AAAP ORN PIP ad	1
Mini‐Symposia II	1
AJA Psychedelics	1
Symposium III	1
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
Is your AAAP Membership expiring this month?	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
Daily cannabis use may cause cannabis‐induced hyperalgesia	1
Cannabis Use PIP Ad	1
Call for review papers 2022	1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Issue Information ‐ ToC	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
AAAP Membership	1
Call for special issue 2023	1
Symposium I	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
Film & Media Workshop	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
Call for Special Issue 2021	1
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	1
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
2023 Advanced Addiction Psychopharmacology Course	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl	1
PCSS exchange AJA Ad	1
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
Issue Information	1
Conference Schedule	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Cannabis and the overdose crisis among US adolescents	1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use	1
Legalization of cannabis in Canada—Local media analysis	1
ORN Advancing racial equity	1
Call for review papers 2023	0

Estimating the effects of prenatal cannabis exposure on birth outcomes	0
	0
Addictions and their treatment	0
Motives for prescription opioid use: The role of alexithymia and distress tolerance	0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study	0
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment	0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	0
2024 Reviewer List	0
	0
Symposia, Medical Update, and Case Conference	0
Issue Information	0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey	0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	0
Medical marijuana access and prolonged opioid use among adolescents and young adults	0
Issue Information ‐ ToC	0
Symposium II	0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam	0
AAAP Psychotherapy Curriculum Series	0
Conference Schedule	0
Is your AAAP membership expiring soon?	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
Stand against stigma	0
Issue Information	0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review	0
Issue Information	0
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health	0
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health	0
Call for Review Papers 2024	0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 2024	0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	0
Travel Award AJA	0
AAAP podcast	0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients	0
PCSS is here to help!	0
Call for review papers 2022	0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	0
Managing Opioid Use Disorder Care in the Era of Fentanyl	0
Issue Information	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder	0
CSAM 2021 scientific conference	0
Film & Media Workshop	0
	0
2023 Reviewer List (n = 223)	0
Trajectories of prescription opioid and heroin use in adulthood	0
AAAP_Call for Review papers‐2024	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
	0
Issue Information	0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
Issue Information ‐ Editorial Board	0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use	0
2022 Self‐Assessment examination	0
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study	0
Become a AAAP Member	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
AAAP Travel Awards Open	0
AAAP PIPS 2023	0
Issue Information ‐ Editorial Board	0
Become a AAAP Member	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
Binge drinking and sexual risk behavior among US sexual and gender minority college students	0
AJA psychedelic Ad	0
AAAP ORN PIP ad	0
Become A AAAP Member!	0
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial	0
AAAP conference awards are open!	0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	0
AAAP's Educational Offerings	0
Psychotherapy Webinar Series AJA	0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
Motivational Interviewing Performance in Practice	0
Call for special issue 2021	0
Call for Special Issue 2022	0
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit	0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	0
Symposium IV	0
AAAP Performance and Practice (PIP) Resources	0
Issue Information	0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
Motivational Interviewing PIP	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
Call for review papers 2023	0
Issue Information ‐ Editorial Board	0
Opioid use disorder and its association with self‐reported difficulties participating in social activities	0
AAAP's Self‐Assessment Examination 2020	0
AAAP Podcast	0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood	0
	0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone	0